VCU Stravitz-Sanyal Institute for Liver Disease

Learn more about @saulkarpen, our April Faculty Spotlight, at bit.ly/4sP7tTQ #livertwitter

Our review on RLSE in MASH -Noninvasive surrogate endpoints of adverse outcomes,... : Hepatology journals.lww.com/hep/abstract/9… @AASLDtweets @EASLnews @BavenoCoop @APASLnews @INASL_Liver @QAnstee @VWSWong @AparnaGoelMD

🌟 In @AGA_Gastro Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease, w/co-author @saulkarpen #livertwitter bit.ly/4snHRNl

In @NatureMedicine New SELECT results: weekly semaglutide cut major heart events and improved a blood marker of fatty liver in people with obesity and heart artery disease—about a 21% risk drop with age-adjusted FIB‑4. @ArunJSanyalVCU #livertwitter go.nature.com/4cm7xVb

NEW in @HEP_Journal A @VCU - @MayoClinic review with @juanpabloarab explores how targeting the microbiome can be a promising approach for treating liver diseases like MASLD, ALD, cirrhosis, hepatic encephalopathy and liver cancer. bit.ly/4swtSFp #livertwitter

The director of VCU's Alcohol Research Center, Dr. Michael Miles, speaks April 8 at the next research webinar. “Brain and Liver Molecular Adaptations in a Mouse Genetic Model of Chronic Progressive Ethanol Consumption.” Register, watch at bit.ly/4tj3Llb #livertwitter

April is #AlcoholAwarenessMonth ♥ An annual campaign intended to boost awareness of the heavy burden that alcohol misuse 🥃 places on affected individuals and their families, as well as its adverse impact on their health and society. Learn more 🔽🔽 healio.com/news/gastroent…

Our @VCUHealth GI team supporting colorectal awareness month through community outreach, education and awareness events 🔊 Every conversation matters. Every screening has potential to save a life! @VCU_Liver @VCUMassey @AmCollegeGastro @AmerGastroAssn @ASGEendoscopy #colorectalcancerawareness #GITwitter

NEW in @AGA_Gastro: Alcohol Industry Influence on Public View and Policymaking: Implications for Liver Health - Gastroenterology bit.ly/3NY5QE5 w/our @juanpabloarab @JVLazarus #livertwitter #alcohol

While at the Amazonian Forum on Metabolic Steatotic Disease (#MASLD 2026), in Belem, Brazil, this past weekend, our Director @ArunJSanyalVCU checked out a river boat clinic that provides metabolic care to the river's residents. READ more: bit.ly/4bGvXIN #livertwitter

Appreciate @Independent's coverage of #alpha-gal syndrome research led by our @vinayjaha. #Tick season is almost upon us! Gastro symptoms are among the most common and confusing signs of #AGS. So GIs need greater awareness of this syndrome. bit.ly/4t1yWkI

What do patients think of AI? @Medscape spoke w/our @vinayjaha about survey results showing they prioritize physician oversight & transparency, with an overwhelming majority saying the physician should retain final decision-making authority. #livertwitter wb.md/3NNmBSf

Our @juanpabloarab and colleagues

NEW in @JAMANetworkOpen: In patients with severe #AlcoholAssociatedHepatitis, higher neighborhood disadvantage was associated w/lower likelihood of #LiverTransplant referral, especially at intermediate MELD scores. #livertwitter @juanpabloarab ja.ma/4bAju82

Regular dental care linked to fewer complications, lower liver cancer risk in veterans with cirrhosis. Our @JasmohanBajaj says ‘it’s time to take orodental health seriously’ to help prevent liver cancer and disease progression. bit.ly/4rPhgI5 #livertwitter

Our new Siemens PET/CT scanner arrived today for installation in our new clinical imaging center. The 7,200 square-foot center is scheduled to open this summer as part of our translational science efforts from pre-clinical to clinical research. #livertwitter

Alcohol-related liver disease could be nearly three times higher than previous estimates, new US study suggests. Find out more in @LancetGastroHep: spkl.io/6017A0wzS

🗣️The @AASLDtweets supports the federal court’s ruling to preserve #hepatitis A/B vaccination for infants and children 🗨️ “We are at a critical inflection point for #vaccine policy in the United States,” Dr. Saul J. Karpen @VCU told @GoHealio healio.com/news/gastroent…

#CGH4ALL @AGA_CGH 📣 🧠 When metabolic dysfunction and alcohol collide, the liver faces a double hit. 🍷➕🧬 Alcohol + metabolic dysfunction = a new clinical challenge. This expert consensus defines how to evaluate, risk-stratify, and manage MetALD, a growing challenge in steatotic liver disease. 🍷⚖️🧬 🔬 MetALD is redefining steatotic liver disease. Experts provide a structured clinical approach to this dual-driver disease at the intersection of MASLD and alcohol use. 📊🩺 #Hepatology #MASLD #MetALD #LiverTwitter Find out more at 👇 🔗 doi.org/10.1016/j.cgh.… Reported by @talal_khurshid @JosephHabibi_MD @DrLoomba @NancyReau @juanpabloarab @ajay_duseja @rabataller @MarkThursz @BrettEFortuneMD @Dr_Vijay_Shah @DougSimonetto @AlinaAllenMD @AlkhouriNaim @mqkMD @scottisaacsmd @serperm @nadimmahmud @RichSterlingMD @NoureddinMD @SanjayaSatapath @norahterrault @ArunJSanyalVCU